Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Eucalyptol, Menthol, Methyl Salicylate, Thymol
Brand Name
Eucalyptol, Menthol, Methyl Salicylate, Thymol
Generic Name
Eucalyptol, Menthol, Methyl Salicylate, Thymol
Active Ingredient
EucalyptolCategory
Non-Standardized Food Allergenic Extract [EPC]
Variants
5
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| .92 mg/mL | MOUTHWASH | ORAL | 70677-1233 |
| .92 mg/mL | MOUTHWASH | ORAL | 70677-1234 |
| .92 mg/mL | MOUTHWASH | ORAL | 53942-855 |
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Eucalyptol, Menthol, Methyl Salicylate, Thymol, you must consult a qualified healthcare professional.
| .92 mg/mL | MOUTHWASH | ORAL | 46122-810 |
| .92 mg/mL | MOUTHWASH | ORAL | 70677-1232 |
Detailed information about Eucalyptol, Menthol, Methyl Salicylate, Thymol
Eucalyptol (1,8-cineole) is a bicyclic monoterpene used as a non-standardized allergenic extract and a therapeutic agent for respiratory inflammation and mucolysis.
The dosage of Eucalyptol can vary significantly based on the condition being treated and the specific formulation used. For respiratory conditions, the following are typical guidelines:
Eucalyptol must be used with extreme caution in the pediatric population.
There are no specific dose adjustment guidelines for patients with renal impairment provided by the manufacturer; however, since the metabolites are excreted renally, patients with severe kidney disease (e.g., GFR < 30 mL/min) should be monitored closely for potential accumulation.
Because Eucalyptol is metabolized by the liver, patients with significant hepatic dysfunction (e.g., Child-Pugh Class B or C) should use this compound with caution. Lower doses or increased dosing intervals may be necessary to prevent toxicity.
Clinical studies have not identified significant differences in response between elderly and younger patients. However, given the higher prevalence of polypharmacy (taking multiple medications) and reduced organ function in the elderly, a starting dose at the lower end of the range is often prudent.
If you miss a dose of Eucalyptol, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up, as this increases the risk of side effects.
Eucalyptol overdose can be life-threatening, particularly in children. Signs of toxicity include:
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Do not induce vomiting unless specifically instructed to do so by a medical professional.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking the medication without medical guidance.
While Eucalyptol is generally well-tolerated when used at recommended dosages, some patients may experience mild side effects. The most frequently reported issues include:
Eucalyptol is a potent bioactive compound. It should only be used for the indications for which it was prescribed or recommended. It is vital to distinguish between pharmaceutical-grade Eucalyptol (1,8-cineole) and generic eucalyptus essential oils, which may contain other impurities or varying concentrations of active ingredients that increase toxicity risks.
No FDA black box warnings for Eucalyptol have been issued as of 2026.
While Eucalyptol has few absolute contraindications regarding drug combinations, it should never be used alongside:
Eucalyptol must NEVER be used in the following circumstances:
Eucalyptol is currently not formally classified into the old FDA pregnancy categories (A, B, C, D, X), but it is generally treated as Category C (risk cannot be ruled out). There are no adequate and well-controlled studies in pregnant women. Animal studies have not shown clear teratogenic (birth defect-causing) effects at therapeutic doses, but terpenes are known to cross the placental barrier. Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. It is especially recommended to avoid use during the first trimester when organogenesis (the formation of organs) occurs.
Eucalyptol is highly lipophilic and is expected to pass into breast milk. While there are no documented cases of toxicity in nursing infants from maternal therapeutic use, the characteristic smell of eucalyptus may be present in the milk, which might lead to infant nursing aversion. Furthermore, because of the sensitivity of infants to Eucalyptol-induced respiratory spasms, breastfeeding mothers should consult their doctor before use and ensure the infant does not come into direct contact with any topical Eucalyptol applied to the chest or breasts.
Eucalyptol (1,8-cineole) is a bicyclic monoterpene that exerts its effects through several distinct molecular mechanisms:
Common questions about Eucalyptol, Menthol, Methyl Salicylate, Thymol
Eucalyptol is primarily used as an adjuvant (add-on) treatment for inflammatory respiratory conditions such as chronic bronchitis, asthma, and Chronic Obstructive Pulmonary Disease (COPD). It works by thinning thick mucus, making it easier to cough up, and by reducing inflammation in the airways. Additionally, it is used in dentistry as a solvent during root canal procedures and in allergy clinics as a non-standardized extract for diagnostic skin testing. Some people also use it topically in balms to relieve minor muscle and joint pain. Always consult your doctor to see if Eucalyptol is appropriate for your specific respiratory or health needs.
The most common side effects of Eucalyptol include gastrointestinal issues such as mild nausea, heartburn, or stomach upset. Many patients also experience 'eucalyptus burps' or a persistent eucalyptus taste in the mouth after taking oral capsules. In some cases, it may cause mild diarrhea or a cooling sensation in the stomach. While these are usually not serious, taking the medication with water 30 minutes before a meal can help minimize digestive discomfort. If these symptoms become severe or persistent, you should contact your healthcare provider for further guidance.
There is no known direct dangerous interaction between Eucalyptol and alcohol; however, caution is advised. Alcohol can irritate the stomach lining and may worsen the gastrointestinal side effects, such as heartburn or nausea, that Eucalyptol sometimes causes. Additionally, if Eucalyptol makes you feel slightly dizzy or lightheaded, alcohol can significantly increase these sensations, potentially leading to impaired coordination. For the best results in treating respiratory infections or inflammation, it is generally recommended to avoid alcohol to allow your immune system to function optimally. Discuss your alcohol consumption with your doctor to ensure it does not interfere with your treatment.
The safety of Eucalyptol during pregnancy has not been established through rigorous clinical trials, and it is generally considered a 'Category C' equivalent. This means that while animal studies may not show clear harm, there is insufficient data in humans to guarantee safety for the developing fetus. Terpenes like Eucalyptol are known to cross the placenta, and their effects on fetal development are not fully understood. Most healthcare providers recommend avoiding Eucalyptol during pregnancy, especially in the first trimester, unless the medical necessity clearly outweighs the potential risks. Always speak with your obstetrician before taking any new supplement or medication while pregnant.
When taken orally in enteric-coated capsules, Eucalyptol is absorbed relatively quickly, with peak blood levels typically reached within 1 to 1.5 hours. Most patients begin to notice a thinning of mucus and a cooling sensation in the airways within the first few hours of the first dose. However, for chronic conditions like COPD or persistent bronchitis, it may take several days of consistent use (usually 3 to 7 days) to experience the full anti-inflammatory benefits and a significant reduction in coughing. If your symptoms do not improve or if they worsen after a week of treatment, you should consult your healthcare provider for a re-evaluation.
Yes, Eucalyptol can generally be stopped suddenly without the risk of physical withdrawal symptoms or 'rebound' effects common with some other respiratory medications. It is not an addictive substance and does not cause chemical dependency. However, if you are using it to manage a chronic condition like asthma or COPD, stopping the medication may result in a return of your original symptoms, such as thick mucus and difficulty breathing. It is always best to discuss your treatment plan with your doctor before making changes, as they can help you determine if your condition is stable enough to discontinue the therapy.
If you miss a dose of Eucalyptol, you should take it as soon as you remember. However, if it is nearly time for your next scheduled dose, it is better to skip the missed dose and simply take your next one at the regular time. You should never take two doses at once to make up for a missed one, as this can increase the concentration of the drug in your system and lead to a higher risk of side effects like dizziness or stomach pain. Keeping a consistent schedule helps maintain a steady level of the medication in your bloodstream for the best therapeutic effect.
There is no clinical evidence to suggest that Eucalyptol causes weight gain. It is a terpene compound that does not contain calories in significant amounts, nor does it affect the metabolic processes or hormones typically associated with weight changes, such as insulin or cortisol. If you experience unexpected weight gain while taking Eucalyptol, it is likely due to another factor, such as other medications you may be taking (like oral steroids for asthma) or changes in your activity level due to your respiratory condition. You should discuss any significant weight changes with your healthcare provider to identify the underlying cause.
Eucalyptol can interact with certain other medications, particularly those processed by the liver's cytochrome P450 enzyme system. It may speed up the metabolism of some drugs, potentially making them less effective. It should also be used with caution if you are taking anti-seizure medications, as Eucalyptol may lower the seizure threshold. While it is often used alongside standard asthma or COPD inhalers, you must provide your doctor with a full list of all prescription drugs, over-the-counter medicines, and herbal supplements you are using. This allows your healthcare provider to check for specific interactions and ensure your treatment combination is safe.
Eucalyptol itself is a specific chemical compound (1,8-cineole) and is available in various forms, including generic essential oils and branded pharmaceutical products like GeloMyrtol or Soledum (primarily in Europe). In the United States, it is often found as an active ingredient in many generic over-the-counter cough and cold preparations, mouthwashes, and topical rubs. While you can find generic versions, it is important to ensure you are using a product intended for your specific route of administration (e.g., oral vs. topical) and that it meets pharmaceutical quality standards. Always check with a pharmacist to ensure the generic product you choose is equivalent to what was recommended.
Other drugs with the same active ingredient (Eucalyptol)
> Warning: Stop taking Eucalyptol and call your doctor immediately if you experience any of the following serious symptoms:
Data on the long-term use of Eucalyptol (beyond 6-12 months) is limited. However, prolonged use of high doses may lead to:
Currently, there are no FDA black box warnings for Eucalyptol. However, the lack of a black box warning does not imply absolute safety. The risks of seizures in children and the potential for severe allergic reactions are the primary safety concerns documented in clinical literature.
Report any unusual or persistent symptoms to your healthcare provider. Monitoring for side effects is an essential part of your treatment plan.
For patients on long-term or high-dose Eucalyptol therapy, healthcare providers may recommend the following monitoring:
Eucalyptol generally does not cause significant sedation; however, because it can cause dizziness or lightheadedness in some individuals, patients should observe their reaction to the medication before driving a vehicle or operating heavy machinery. If you feel 'foggy' or unsteady, avoid these activities.
There is no direct contraindication between Eucalyptol and moderate alcohol consumption. However, alcohol can increase the risk of gastrointestinal irritation and may compound the dizziness sometimes associated with Eucalyptol. It is generally advisable to limit alcohol intake while treating respiratory conditions to support the immune system.
Eucalyptol does not typically require a tapering period. It can usually be stopped abruptly without withdrawal symptoms. However, if you are taking it for a chronic condition like COPD, stopping the medication may lead to a return of thick mucus and increased coughing. Always consult your doctor before stopping a prescribed treatment regimen.
> Important: Discuss all your medical conditions, including any history of seizures or digestive issues, with your healthcare provider before starting Eucalyptol.
For each major interaction, the mechanism usually involves the induction or inhibition of hepatic enzymes or a pharmacodynamic synergy (where two drugs have similar effects on the body).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking to prevent dangerous interactions.
Conditions requiring a careful risk-benefit analysis by a physician include:
Patients who are allergic to the following substances should use Eucalyptol with extreme caution, as they may experience a cross-allergic reaction:
> Important: Your healthcare provider will evaluate your complete medical history, including any history of allergies or organ dysfunction, before prescribing Eucalyptol.
As previously noted, Eucalyptol is strictly contraindicated in children under 2 years of age. In older children (ages 2-12), it should be used with caution. The pediatric nervous system is more susceptible to the excitatory effects of terpenes, which can lead to agitation or seizures. Eucalyptol is NOT approved for the treatment of 'croup' or other acute viral infections in children unless specifically directed by a pediatrician, as the risk of airway irritation often outweighs the mucolytic benefit in small airways.
In patients over 65, the primary concerns are renal clearance and polypharmacy. While Eucalyptol does not typically cause falls, the dizziness associated with it could increase fall risk in frail elderly patients. Additionally, elderly patients are more likely to have underlying gastrointestinal sensitivity, making the enteric-coated forms essential for this population.
In patients with a Glomerular Filtration Rate (GFR) below 60 mL/min, the excretion of Eucalyptol metabolites may be delayed. While dose adjustments are not standardized, clinicians often monitor for signs of cumulative toxicity. Dialysis is not an effective way to clear Eucalyptol from the system due to its high volume of distribution and lipophilicity.
Since the liver (via CYP450) is the sole site of metabolism, patients with Child-Pugh Class B or C impairment are at high risk for Eucalyptol toxicity. In these patients, the half-life of the drug may be significantly extended, leading to CNS effects. Use is generally discouraged in cases of severe hepatic failure.
> Important: Special populations require individualized medical assessment and should never start Eucalyptol without professional consultation.
The onset of the mucolytic effect typically occurs within 30 to 60 minutes of oral administration. The duration of effect lasts approximately 4 to 6 hours. Eucalyptol does not appear to cause significant 'rebound' congestion, a common issue with sympathomimetic decongestants. Tolerance development is rare, though the underlying disease state (e.g., COPD) may progress, requiring additional therapies.
| Parameter | Value |
|---|---|
| Bioavailability | >90% (Oral) |
| Protein Binding | ~50-70% (Estimated) |
| Half-life | 1.5 - 2.5 hours |
| Tmax | 1.0 - 1.5 hours |
| Metabolism | Hepatic (CYP3A4, CYP2B6) |
| Excretion | Renal (>80% as metabolites), Lungs (trace) |
Eucalyptol is classified as a Non-Standardized Food/Fungal Allergenic Extract [EPC] in the context of allergy medicine. In general respiratory pharmacology, it is considered a Terpene-based Mucolytic or Expectorant. It is chemically related to other terpenes like menthol, camphor, and thymol, though it has a distinct safety and efficacy profile.